Dr. Daud is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th St
PCMB
San Francisco, CA 94143Phone+1 415-353-9900
Summary
- Im a medical oncologist specializing in melanoma
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
Indiana University School of MedicineResidency, Internal Medicine, 1994 - 1997
Government Medical College NagpurClass of 1985
Certifications & Licensure
CA State Medical License 2008 - 2026
FL State Medical License 2001 - 2010
NY State Medical License 1997 - 2003
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Trial of pIL-12 Electroporation Malignant Melanoma Start of enrollment: 2012 Feb 14
- A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- Distinguishing between help and harm: Helper T cell subsets and immune-related adverse events.Alexandra M Haugh, Adil I Daud
The Journal of Clinical Investigation. 2024-10-15 - Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response.Zoe Quandt, Saya Jacob, Muhammad Zaki Hidayatullah Fadlullah, Chaorong Wu, Clinton Wu
BJC Reports. 2024-06-24 - 3 citationsTherapeutic Strategies in BRAF V600 Wild-Type Cutaneous Melanoma.Alexandra Haugh, Adil I Daud
American Journal of Clinical Dermatology. 2024-05-01
Press Mentions
Sequencing Matters – Combination Dabrafenib/Trametinib Versus Nivolumab/Ipilimumab for Advanced BRAF-Mutant Melanoma: The DREAMseq TrialMarch 9th, 2023- OncoSec Hosting an Investor and Analyst Day Webinar Showcasing Positive KEYNOTE-695 Data in Anti-PD-1 Checkpoint Refractory Metastatic MelanomaNovember 5th, 2020
Dubai: Zulekha Hospital Announces Free Colon Cancer Check-Ups for UAE ResidentsFebruary 17th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
